Juliana Inês Weber

Dr. Juliana Inês Weber

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2023 in Cells
Verified
Journal Article
Open access
PDF file
JWJuliana Inês Weber
Juliana Inês Weber
Maria Armanda RodriguesMaria Armanda Rodrigues
Maria Armanda Rodrigues
ABAna Sofia Valério Bolas
Ana Sofia Valério Bolas
TNTelmo Nunes
Telmo Nunes
MCManuela Carvalheiro
Manuela Carvalheiro
Gabriela Santos-GomesGabriela Santos-Gomes
Gabriela Santos-Gomes
Leishmaniasis is a parasitic disease caused by different species of Leishmania and transmitted through the bite of sand flies vector. Macrophages (MΦ), the target cells of Leishmania parasites, are phagocytes that play a crucial role in the innate immune microbial defense and are antigen-presenting cells driving the activation of the acquired immune response. Exploring parasite–host communication may be key in restraining parasite dissemination in the host. Extracellular vesicles (EVs) constitute a group of heterogenous cell-derived membranous structures, naturally produced by all cells and with immunomodulatory potential over target cells. This study examined the immunogenic potential of EVs shed by L. shawi and L. guyanensis in MΦ activation by analyzing the dynamics of major histocompatibility complex (MHC), innate immune receptors, and cytokine generation. L. shawi and L. guyanensis EVs were incorporated by MΦ and modulated innate immune receptors, indicating that EVs cargo can be recognized by MΦ sensors. Moreover, EVs induced MΦ to generate a mix of pro- and anti-inflammatory cytokines and favored the expression of MHCI molecules, suggesting that EVs antigens can be present to T cells, activating the acquired immune response of the host. Since nano-sized vesicles can be used as vehicles of immune mediators or immunomodulatory drugs, parasitic EVs can be exploited by bioengineering approaches for the development of efficient prophylactic or therapeutic tools for leishmaniasis.

Verified
Journal Article
Open access
PDF file
Maria Armanda RodriguesMaria Armanda Rodrigues
Maria Armanda Rodrigues
JWJuliana Inês Weber
Juliana Inês Weber
João Durães-OliveiraJoão Durães-Oliveira
João Durães-Oliveira
Claudia Jassica Gonçalves MorenoClaudia Jassica Gonçalves Moreno
Claudia Jassica Gonçalves Moreno
MFMicheli Ferla
Micheli Ferla
Gabriela Santos-GomesGabriela Santos-Gomes
Gabriela Santos-Gomes
Trypanosomatids constitute a family of parasitic protozoa that cause significant human and veterinary diseases that are classified as neglected zoonotic diseases (NZDs). In a rapidly evolving world, these diseases have the potential to become a world health problem no longer solely associated with low-income countries. Therefore, the development of new strategies to control and restrain the dissemination of trypanosomatids is imperative. Extracellular vesicles (EVs) are a heterogeneous group of membrane-enclosed vesicles released by prokaryotic and eukaryotic cells. They can be found in diverse body fluids that carry biologically active molecules, including proteins, nucleic acids, lipids, and carbohydrates. EVs participate in cell-to-cell communication by delivering their cargo content to recipient cells. Thus, EVs play a role in regulating normal physiological processes, including immune surveillance and tissue repair, as well as being involved in pathological conditions, like cancer. In recent years, EVs have attracted significant attention from the scientific community, mainly due to their immune regulatory properties. Therefore, this review examines the role played by trypanosomatid-derived EVs in leishmaniases and trypanosomiasis, highlighting their biological role in host–parasite communication and exploring their potential future applications in controlling NZDs, especially those caused by trypanosomatids.